BBIXF OTC
Bonus Biogroup Ltd.
1W: +0.0%
1M: +0.0%
3M: -63.6%
YTD: -50.0%
1Y: -42.9%
3Y: +33.3%
5Y: -60.0%
$0.04
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$28M
+6.6% ▲
Net Income
-$28M
+2.5% ▲
EPS (Diluted)
$-0.02
+2.5% ▲
EBITDA
-$26M
+6.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $2M | $4M | $3M | $0 | $0 |
| Gross Profit | -$2M | -$4M | -$3M | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $11M | $21M | $21M | $19M | $18M |
| SG&A Expenses | $3M | $31M | $5M | $11M | $10M |
| Operating Expenses | $18M | $61M | $34M | $30M | $28M |
| Operating Income | -$19M | -$65M | -$37M | -$30M | -$28M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $408K | $569K | $891K | $0 | $0 |
| Income Before Tax | -$22M | -$90M | -$39M | -$29M | -$28M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$22M | -$90M | -$39M | -$29M | -$28M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.02 | $-0.08 | $-0.03 | $-0.02 | $-0.02 |
| EBITDA | -$18M | -$88M | -$35M | -$28M | -$26M |
| Shares Outstanding | 983M | 1.15B | 1.17B | 1.17B | 1.17B |